Llor Carl, Sierra Nuria, Hernández Silvia, Moragas Ana, Hernández Marta, Bayona Carolina, Miravitlles Marc
Primary Care Centre Jaume I, Tarragona, University Rovira i Virgili, Spain.
J Antimicrob Chemother. 2009 Feb;63(2):396-9. doi: 10.1093/jac/dkn472. Epub 2008 Nov 16.
To assess the drug compliance observed among patients with lower respiratory tract infection treated with once-daily, twice-daily and thrice-daily antibiotic regimens.
We performed a prospective study in the primary care setting including patients with suspected bacterial lower respiratory tract infections, not allergic to beta-lactam antimicrobials, macrolides or quinolones, treated with several antibiotic regimens. Patient compliance was assessed by electronic monitoring.
A total of 251 patients were enrolled (136 in the thrice-daily group, 70 in the twice-daily group and 45 in the once-daily group). The mean container openings ranged from 94.3 +/- 12.6% with once-daily antibiotics to 74.8 +/- 17.7% with thrice-daily drugs (P < 0.001). Seventy-five patients in the thrice-daily group took at least 80% of the medications (55.1%), being significantly less than those receiving twice-daily (71.4%) or once-daily (86.7%; P < 0.001) drugs. Only 20.6% of the patients assigned to the thrice-daily regimens opened the container every 8 +/- 4 h during at least 80% of the course. Among the patients assigned the same number of doses daily, compliance was better with the shortest antibiotic courses, being worse with schedules of 7 days or more. The percentage of patients who opened the MEMS container the satisfactory number of times a day was lower among the thrice-daily regimens. Moreover, the thrice-daily group more frequently forgot the afternoon dose.
The rate of compliance was very low, mainly when antibiotics were administered thrice daily and in regimens of 7 days or more. New strategies addressed to improve antibiotic drug compliance are, therefore, necessary.
评估每日一次、每日两次和每日三次抗生素治疗方案治疗的下呼吸道感染患者的药物依从性。
我们在基层医疗环境中进行了一项前瞻性研究,纳入疑似细菌性下呼吸道感染、对β-内酰胺类抗菌药物、大环内酯类或喹诺酮类不过敏且接受多种抗生素治疗方案的患者。通过电子监测评估患者的依从性。
共纳入251例患者(每日三次组136例,每日两次组70例,每日一次组45例)。每日一次抗生素治疗时平均容器开启率为94.3±12.6%,每日三次用药时为74.8±17.7%(P<0.001)。每日三次组75例患者服用了至少80%的药物(55.1%),显著低于每日两次组(71.4%)或每日一次组(86.7%;P<0.001)。在至少80%的疗程中,分配到每日三次治疗方案的患者中只有20.6%每8±4小时打开一次容器。在每日给药次数相同的患者中,抗生素疗程最短的依从性较好,7天或更长疗程的依从性较差。每日三次治疗方案中,每天打开MEMS容器次数达满意次数的患者百分比更低。此外,每日三次组更频繁地忘记下午的剂量。
依从率非常低主要是在每日三次给药以及疗程为7天或更长疗程时。因此需要新的策略来提高抗生素药物依从性。